University of Patras
ΔΙΕΡΕΥΝΗΣΗ ΤΗΣ ΕΚΚΡΙΣΗΣ ΤΗΣ ΑΥΞΗΤΙΚΗΣ ΟΡΜΟΝΗΣ ΚΑΙ ΤΗΣ ΙΝΣΟΥΛΙΝΗΣ ΣΤΟ ΣΥΝΔΡΟΜΟ ΤΩΝ ΠΟΛΥΚΥΣΤΙΚΩΝ ΩΟΘΗΚΩΝ
Abstract
dc:descriptionTHE PURPOSE OF THE STUDY WAS TO INVESTIGATE 1) THE RESPONSE OF GROWTH HORMONE (GH) IN WOMEN WITH THE SYNDROME OF POLYCYSTIC OVARIES (PCOS) AND 2) THE POSSIBLE MODULATORY ACTION OF DOPAMINE ON THE SECRETION OF INSULIN. THEREFORE WE STUDIED NINETEEN WOMEN WITH PCOS (ELEVEN WITH FULL EXPRESSION AND EIGHT WITH ONLY PARTIAL EXPRESSION OF THE SYNDROME) AND ELEVEN NORMAL WOMEN WITH NO EVIDENCE OF PCOS (CONTROL GROUP). IN THE FIRST PART OF THE STUDY, WE ESTIMATED THE GHRESPONSE TO A) THE IV INFUSION (4 ΜG/KG.MIN FOR 3H) OF DOPAMINE AND B) THE BOLLUS IV ADMINISTRATION OF GHRH (1 - 29) 1 ΜG/KG. IN THE SECOND PART, WE STUDIED THE EFFECT OF DOPAMINE IV INFUSION ON THE RESPONSES OF GLUCOSE INSULIN AND C - PEPTIDE LEVELS TO THE ADMINISTRATION OF 75 G OF GLUCOSE PER OS (OGTT). THERESULTS OF THE STUDY DEMONSTRATED THAT: 1) THE GH RESPONSES TO DOPAMINE AND GHRH ADMINISTRATION WERE FOUND TO BE SIGNIFICANTLY LOWER IN PCOS THAN IN THE CONTROL GROUP. IN CONTRAST THE IGF - 1 LEVELS DID NOT DIFFER BETWEEN THE GROUPS.THESE RESULTS ARE CONSISTENT WITH THE PRESENCE OF AN ABNORMALLY REGULATED GH/IGF - 1 SYSTEM IN WOMEN WITH PCOS, IN PARTICULAR IN THOSE WITH THE FULL EXPRESSION OF THE SYNDROME. 2) DOPAMINE INFUSION INDUCED A SIGNIFICANT REDUCTION INTHE INSULIN AND C - PEPTIDE RESPONSE TO THE ORAL GLUCOSE CHALLENGE, WHILE THEPLASMA GLUCOSE LEVELS REMAINED UNCHANGED, IN THE PCOS GROUP. THESE RESULTS SUGGEST THE PRESENCE EITHER OF A FUNCTIONAL ABNORMALITY OF THE DOPAMINERGIC RECEPTOR OF THE PANCREAS OR AN UP - REGULATION OF THE Α - ADRENERGIC RECEPTOR, IN THE EXPERIMENTAL GROUP.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 1997
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kounadi, Theodora
- Κουνάδη, Θεοδώρα
Subjects
dc:subject × 23- Dopamine
- Dopaminergic system
- GHRH
- GROWTH - HORMONE
- Growth hormone
- IGF-I
- Insulin
- Insulin - like growth factor I
- Insulin resistance
- Polycystic ovarian syndrome
- RELEASING HORMONE
- Αυξητική ορμόνη
- ΕΚΛΥΤΙΚΟΣ ΥΠΟΘΑΛΑΜΙΚΟΣ ΠΑΡΑΓΩΝ ΑΥΞΗΤΙΚΗΣ ΟΡΜΟΝΗΣ
- Ινσουλιναντοχή
- Ινσουλίνη
- Ινσουλινόμορφος αυξητικός παράγων Ι
- Ντοπαμινεργικό σύστημα
- Ντοπαμίνη
- Σύνδρομο πολυκυστικών ωοθηκών
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/8583